These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7697342)

  • 101. Cell-cycle regulators and cancer.
    Kamb A
    Trends Genet; 1995 Apr; 11(4):136-40. PubMed ID: 7732591
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Role of a cell cycle regulator in hereditary and sporadic cancer.
    Kamb A
    Cold Spring Harb Symp Quant Biol; 1994; 59():39-47. PubMed ID: 7587092
    [No Abstract]   [Full Text] [Related]  

  • 103. Cell division cycle alterations and human tumors.
    Della Ragione F; Borriello A; Della Pietra V; Cucciolla V; Oliva A; Barbarisi A; Iolascon A; Zappia V
    Adv Exp Med Biol; 1999; 472():73-88. PubMed ID: 10736618
    [No Abstract]   [Full Text] [Related]  

  • 104. The CDKN2A (p16) gene and human cancer.
    Foulkes WD; Flanders TY; Pollock PM; Hayward NK
    Mol Med; 1997 Jan; 3(1):5-20. PubMed ID: 9132280
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Sherr CJ; Roberts JM
    Genes Dev; 1995 May; 9(10):1149-63. PubMed ID: 7758941
    [No Abstract]   [Full Text] [Related]  

  • 106. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.
    Tsihlias J; Kapusta L; Slingerland J
    Annu Rev Med; 1999; 50():401-23. PubMed ID: 10073286
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Parsing Ink4a/Arf: "pure" p16-null mice.
    Sherr CJ
    Cell; 2001 Sep; 106(5):531-4. PubMed ID: 11551500
    [No Abstract]   [Full Text] [Related]  

  • 108. Cellular senescence and cancer.
    Barrett JC; Annab LA; Alcorta D; Preston G; Vojta P; Yin Y
    Cold Spring Harb Symp Quant Biol; 1994; 59():411-8. PubMed ID: 7587095
    [No Abstract]   [Full Text] [Related]  

  • 109. Two tracks but one race? Cancer genetics.
    Sidransky D
    Curr Biol; 1996 May; 6(5):523-5. PubMed ID: 8805269
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
    Larsen CJ
    Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
    [TBL] [Abstract][Full Text] [Related]  

  • 112. p16INK4A as a human tumor suppressor.
    Shapiro GI; Rollins BJ
    Biochim Biophys Acta; 1996 Mar; 1242(3):165-9. PubMed ID: 8603068
    [No Abstract]   [Full Text] [Related]  

  • 113. Cyclin-dependent kinase inhibitors and human cancer.
    Kamb A
    Curr Top Microbiol Immunol; 1998; 227():139-48. PubMed ID: 9479829
    [No Abstract]   [Full Text] [Related]  

  • 114. [Treatment of arthritis with cyclin-dependent kinase inhibitor p 16INK4a gene].
    Kohsaka H; Taniguchi K; Nonomura Y; Nagasaka K; Inoue N; Nasu K; Miyasaka N
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):397-9. PubMed ID: 10726472
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 6.